Systematic Reviews
Copyright ©The Author(s) 2025.
World J Meta-Anal. Jun 18, 2025; 13(2): 105511
Published online Jun 18, 2025. doi: 10.13105/wjma.v13.i2.105511
Table 1 Study summary characteristics[14-21]
Ref.
Country
Geographical zone
Study type
Sample size
Patient population
Age group
Males, %
Females, %
Exposure
Primary outcome measurement
Reimer-Taschenbrecker et al[14], 2023Chicago, United StatesAmericasCross-sectional study216Children with AD5-17 years41.7058.30SESGeographic location, health insurance type, family income, parent education level, and household size
Jeong and Choi[15], 2024KoreaAsiaSurvey2048Children with allergic conditions like atopic dermatitis, asthma, and allergic rhinitis0 ≤ 5 yearsNo separate dataNo separate dataHousehold incomeHousehold income
Landau et al[16], 2024IsraelMiddle EastCross-sectional study77525Children with AD diagnosis (Cases) and pediatric population attending wellness visits (Controls)Cases: < 3 years of age, Controls: < 18 years of age56.6043.40SESSocioeconomic status
Tawfik et al[17], 2023East LondonEuropeCross-sectional study460Infants & children, young adults of Bangladeshi origin with atopic eczema2 months to 30 years old57.0043SESJob/income
Andersson et al[18], 2023GreenlandAmericasCross-sectional study839Pediatric population with AD0–7 years49.8050.20SESParental educational background, housing status
Kim et al[19], 2023KoreaAsiaCross-sectional study980Participants with the presence of allergic conditions, asthma/ADLess than or equal to 18 years of age64.1035.90SESHousehold income
Agiwal et al[20], 2023IndiaAsiaProspective, descriptive study380Pediatric AD populationUp to 15 years of age56.3043.70SESSocio-economic status, residential area
Weil et al[21], 2022IsraelMiddle EastRetrospective case-control study93432Pediatric AD populationLess than 6 months to more than or equal to 18 years of age47.7052.30SESResidential area, socioeconomic status